Pr e s id e n t ’s C a n c e r Pa n e l ( PC P)
LaSalle D. Leffall, Jr., M.D., F.A.C.S., Chair
Margaret Kripke, Ph.D.
N a t i o n a l C a n c e r I n s t it u t e ( N C I) , N a t io n a l In s t it u t e s o f H e a lt h ( N IH )
Abby Sandler, Ph.D., Executive Secretary, PCP, NCI
Pa n e l is t s
Michael C.R. Alavanja, Dr.P.H., Senior Investigator, Division of Cancer Epidemiology and
Genetics, National Cancer Institute
Laura E. Beane Freeman, Ph.D., Research Fellow, Division of Cancer Epidemiology and
Genetics, National Cancer Institute
Suzanne E. Fenton, Ph.D., Research Biologist, Reproductive Toxicology Division, U.S.
Environmental Protection Agency
Joan D. Flocks, J.D., M.A., Director, Social Policy Division, Center for Governmental
Responsibility, University of Florida Levin College of Law
Tyrone B. Hayes, Ph.D., Professor, Department of Integrative Biology, University of California, Berkeley
Heather Logan, Director, Cancer Control Policy and Information, Canadian Cancer Society
Marion Moses, M.D., Founder and President, Pesticide Education Center
Peggy Reynolds, Ph.D., M.P.H., Senior Research Scientist, Northern California Cancer Center
Sandra Steingraber, Ph.D., Scholar in Residence, Interdisciplinary and International Studies
Program, Ithaca College
Mary H. Ward, Ph.D., Senior Investigator, Division of Cancer Epidemiology and Genetics,
National Cancer Institute
OPENING REMARKS—LaSALLE D. LEFFALL, JR., M.D., F.A.C.S.
On behalf of the Panel, Dr. Leffall welcomed invited participants and the public to the meeting.
He introduced Panel members, provided a brief overview of the history and purpose of the Panel, and described the aims of the current series of meetings.
Indianapolis, IN
1
October 21, 2008